Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NATR
NATR logo

NATR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
23.810
Open
23.600
VWAP
23.62
Vol
80.97K
Mkt Cap
416.33M
Low
23.260
Amount
1.91M
EV/EBITDA(TTM)
8.36
Total Shares
17.51M
EV
322.44M
EV/OCF(TTM)
9.13
P/S(TTM)
0.92
Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk.
Show More

Events Timeline

(ET)
2026-03-10
16:30:00
Company Expects FY26 Adjusted EBITDA of $50M-$54M
select
2026-03-10
16:20:00
Nature's Sunshine Reports Q4 Revenue of $123.81M
select
2025-12-04 (ET)
2025-12-04
10:10:00
Nature's Sunshine Appoints Erich Fritz as EVP, Global Supply Chain
select
2025-10-15 (ET)
2025-10-15
09:05:56
Kenneth Romanzi named CEO of Nature's Sunshine
select
2025-06-26 (ET)
2025-06-26
08:22:16
Nature's Sunshine 2.85M share Spot Secondary priced at $12.00
select

News

seekingalpha
9.5
03-10seekingalpha
Nature's Sunshine Products Reports Strong Q4 2025 Earnings and Growth Vision
  • Significant Sales Growth: Nature's Sunshine achieved net sales of $123.8 million in Q4 2025, representing a 5% year-over-year increase, marking the company's second-largest quarterly performance in history and demonstrating strong global market presence.
  • Improved Profitability: The adjusted EBITDA for Q4 reached $11.9 million, up 16% year-over-year, while GAAP net income was $4.1 million, indicating a continuous improvement in profitability that enhances investor confidence.
  • Positive Future Outlook: The company expects net sales for 2026 to range between $500 million and $515 million, reflecting a year-over-year growth of 4% to 7%, with plans for strategic investments in technology infrastructure and customer acquisition to support long-term growth.
  • Accelerated Digital Transformation: Digital business revenue surged by 47% year-over-year, with digital subscriptions accounting for 47% of total revenue, indicating significant progress in the company's digital transformation efforts, which are expected to further drive future sales growth.
seekingalpha
9.5
03-10seekingalpha
Nature's Sunshine Q4 Earnings Beat Expectations with Strong Revenue Growth
  • Strong Earnings Report: Nature's Sunshine reported a Q4 non-GAAP EPS of $0.30, beating expectations by $0.12, which highlights a significant improvement in profitability and boosts investor confidence.
  • Revenue Growth: The company achieved Q4 revenue of $123.8 million, reflecting a 4.7% year-over-year increase and surpassing market expectations by $2.3 million, indicating robust demand for its products and solid market performance.
  • Future Outlook: Nature's Sunshine anticipates full-year 2026 net sales to range between $500 million and $515 million, with adjusted EBITDA expected to be between $50 million and $54 million, demonstrating confidence in future growth prospects.
  • Market Reaction: Following the earnings release, market interest in Nature's Sunshine has increased, with analysts expressing optimism about its future performance, potentially attracting more investor attention.
Yahoo Finance
9.5
02-27Yahoo Finance
Nature's Sunshine Stock Soars 63.7% Amid Mixed Outlook
  • Impressive Stock Performance: Nature's Sunshine's stock has surged by 63.7% over the past six months, reaching a new 52-week high of $27.62 per share, reflecting market optimism about its short-term performance, yet raising concerns about long-term growth potential.
  • Weak Revenue Growth: Despite a solid quarterly performance, the company's compounded annual growth rate over the past three years stands at only 2.8%, significantly below industry standards, indicating a lack of long-term sales growth capability that may undermine investor confidence.
  • Limited Distribution Channels: With $474.5 million in revenue over the past year, Nature's Sunshine operates as a small consumer staples company, which places it at a disadvantage in negotiations with larger competitors, thereby restricting its market potential and growth opportunities.
  • Dismal Future Growth Projections: Wall Street analysts forecast a mere 3.1% revenue growth for Nature's Sunshine over the next 12 months, suggesting that its new products are unlikely to drive significant sales increases, which may lead investors to adopt a cautious stance regarding its future performance.
PRnewswire
5.0
02-06PRnewswire
Doseology Sciences Launches New Caffeine Pouches Amid Market Shift
  • Market Transformation: The functional market is projected to grow from $164 billion to $240 billion, indicating strong consumer demand for practical products, positioning Doseology Sciences at the heart of this high-growth cycle.
  • New Product Pilot: Doseology began pilot production of caffeine energy pouches in January 2026, utilizing a nicotine-free, portable format aimed at meeting consumer demand for alternative energy drinks, which is expected to enhance market competitiveness.
  • Brand Acquisition: In December 2024, Doseology acquired the Feed That Brain brand for $400,000, strengthening its position in the rapidly growing energy drink and sugar-free alternatives market, facilitating future product innovation.
  • Strategic Advisor Appointment: The company appointed Joseph Mimran as a strategic advisor under a three-year contract valued at $400,000, aiming to leverage his industry experience to drive product development and market compliance, further enhancing Doseology's market influence.
Newsfilter
5.0
02-06Newsfilter
Doseology Launches Innovative Energy Product Line
  • Market Growth Potential: The functional market is projected to expand from $164 billion to over $240 billion, indicating strong consumer demand for utility-driven products, positioning Doseology at the forefront of this high-growth cycle.
  • New Product Pilot: Doseology initiated pilot production of caffeine-based energy pouches in January 2026, utilizing nicotine-free portable packaging to meet consumer demand for healthier alternatives, which is expected to significantly enhance market competitiveness.
  • Strategic Brand Acquisition: Doseology acquired the Feed That Brain brand for $400,000, integrating functional product design with market trends to strengthen its position in the energy drink and alternative caffeine product sectors.
  • Executive Recruitment: The company appointed Joseph Mimran as Strategic Advisor with a three-year contract valued at $400,000, aiming to leverage his extensive retail experience to drive Doseology's product development and market expansion.
Globenewswire
5.0
2025-12-15Globenewswire
Synergy Worldwide's Pro-Argi-9+ Named #1 L-Arginine Supplement by Euromonitor
  • Global Recognition: Synergy Worldwide's Pro-Argi-9+ has been named the world's #1 L-arginine supplement by Euromonitor International, reinforcing the product's leadership in the health and wellness sector and is expected to drive sales growth.
  • Scientific Formula: Pro-Argi-9+ features clinically researched ingredients, combining L-arginine and L-citrulline to enhance nitric oxide production, thereby improving blood circulation and boosting overall health and vitality for users.
  • Market Impact: This certification not only elevates Pro-Argi-9+'s market visibility but also attracts more consumers to Synergy's science-based nutritional solutions, helping the company stand out in the competitive dietary supplement market.
  • Leadership Showcase: Executives at Synergy Worldwide noted that the success of Pro-Argi-9+ reflects the company's marketing efforts and leadership globally, which is expected to further enhance brand loyalty and market share.
Wall Street analysts forecast NATR stock price to rise
2 Analyst Rating
Wall Street analysts forecast NATR stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
22.00
Averages
22.50
High
23.00
Current: 0.000
sliders
Low
22.00
Averages
22.50
High
23.00
DA Davidson
Buy
maintain
$23 -> $33
AI Analysis
2026-03-12
Reason
DA Davidson
Price Target
$23 -> $33
AI Analysis
2026-03-12
maintain
Buy
Reason
DA Davidson raised the firm's price target on Nature's Sunshine to $33 from $23 and keeps a Buy rating on the shares. The company's beat and raise trend continues with Q4 results comfortably above consensus forecasts, and the firm sees further upward revisions as results underscore the extent to which the company's portfolio is under-penetrated across key markets, the analyst tells investors in a research note.
Canaccord
Susan Anderson
Buy
maintain
$29 -> $33
2026-03-11
Reason
Canaccord
Susan Anderson
Price Target
$29 -> $33
2026-03-11
maintain
Buy
Reason
Canaccord analyst Susan Anderson raised the firm's price target on Nature's Sunshine to $33 from $29 and keeps a Buy rating on the shares. The firm noted they reported Q4 results that showed strength across all regions and strong growth in its digital business.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NATR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nature's Sunshine Products Inc (NATR.O) is 22.67, compared to its 5-year average forward P/E of 13.77. For a more detailed relative valuation and DCF analysis to assess Nature's Sunshine Products Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
13.77
Current PE
22.67
Overvalued PE
60.59
Undervalued PE
-33.05

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
5.83
Current EV/EBITDA
5.98
Overvalued EV/EBITDA
7.34
Undervalued EV/EBITDA
4.32

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.64
Current PS
0.75
Overvalued PS
0.79
Undervalued PS
0.48

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

create a screener for stock with low float.
Intellectia · 32 candidates
Market Cap: 50.00M - 1.50BRelative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000Month Price Change Pct: >= $10.00Shares Outstanding: <= 30,000,000
Ticker
Name
Market Cap$
top bottom
CTS logo
CTS
CTS Corp
1.45B
ALX logo
ALX
Alexander's Inc
1.26B
PDS logo
PDS
Precision Drilling Corp
991.27M
MOFG logo
MOFG
Midwestone Financial Group Inc (IOWA)
946.70M
ODC logo
ODC
Oil-Dri Corporation of America
850.84M
VPG logo
VPG
Vishay Precision Group Inc
621.59M

Whales Holding NATR

S
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Holding
NATR
+5.83%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nature's Sunshine Products Inc (NATR) stock price today?

The current price of NATR is 23.78 USD — it has increased 0.59

What is Nature's Sunshine Products Inc (NATR)'s business?

Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk.

What is the price predicton of NATR Stock?

Wall Street analysts forecast NATR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NATR is22.50 USD with a low forecast of 22.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nature's Sunshine Products Inc (NATR)'s revenue for the last quarter?

Nature's Sunshine Products Inc revenue for the last quarter amounts to 123.81M USD, increased 4.74

What is Nature's Sunshine Products Inc (NATR)'s earnings per share (EPS) for the last quarter?

Nature's Sunshine Products Inc. EPS for the last quarter amounts to 0.23 USD, decreased -1250.00

How many employees does Nature's Sunshine Products Inc (NATR). have?

Nature's Sunshine Products Inc (NATR) has 806 emplpoyees as of March 30 2026.

What is Nature's Sunshine Products Inc (NATR) market cap?

Today NATR has the market capitalization of 416.33M USD.